Introduction
============

COPD is characterized by airflow limitation and is associated with inflammatory changes that lead to dyspnea, sputum purulence, and persistent coughing. The disease trajectory is one of progressive decline, punctuated by frequent acute exacerbations in symptoms. Patients with COPD have an average of three acute exacerbations per year, and these are the second biggest cause of unplanned hospital admissions in the UK.[@b1-copd-12-1705]--[@b3-copd-12-1705] As COPD is irreversible, and health-related quality of life (HRQOL) in patients with COPD tends to be low, optimizing HRQOL and reducing hospital admissions have become key priorities in COPD management.[@b4-copd-12-1705],[@b5-copd-12-1705]

Self-management planning is a recognized quality standard of the National Institute for Health and Care Excellence (NICE) guidelines in the UK,[@b2-copd-12-1705] and a joint statement by the American Thoracic Society/European Respiratory Society[@b6-copd-12-1705] emphasized its importance in quality of care. Self-management interventions (SMIs) encourage patients to monitor symptoms when stable and to take appropriate action when symptoms begin to worsen.[@b2-copd-12-1705] However, there is no consensus on the form and content of effective SMIs and the variation in content may explain previous heterogeneity in effectiveness.[@b2-copd-12-1705],[@b7-copd-12-1705],[@b8-copd-12-1705] A recent Health Technology Assessment (HTA) report on the efficacy of self-management for COPD recommended that future research should 1) "try to identify which are the most effective components of interventions and identify patient-specific factors that may modify this", and that 2) "behavior change theories and strategies that underpin COPD SMIs need to be better characterized and described".[@b8-copd-12-1705] To enable better comparison and replication of intervention components, taxonomies have been developed to classify potential active ingredients of interventions according to preestablished descriptions of behavior change techniques (BCTs).[@b9-copd-12-1705] BCTs are defined as "an observable, replicable, and irreducible component of an intervention designed to alter or redirect causal processes that regulate behavior".[@b9-copd-12-1705] While recent reviews have conducted content analysis to help identify effective components of SMIs for patients with COPD through individual patient data analysis,[@b10-copd-12-1705],[@b11-copd-12-1705] the coding of intervention content was not performed with established taxonomies and clear understanding between the BCT and the targeted behavior was absent (eg, symptom management, physical activity, mental health management, etc).

This systematic review aims to summarize the current evidence base on the effectiveness of SMIs for improving HRQOL in people with COPD. Conclusions across reviews have been synthesized and evaluated within the context of how self-management was defined. Meta-analyses were performed that explore the relationship between health behaviors the SMIs target, the BCT they use to target behaviors, and subsequent improvement in HRQOL and health care utilization. In addition, we explore the extent to which trial and intervention features influence SMI effects.

Method
======

Search strategy and selection criteria
--------------------------------------

The current review, registered with PROSPERO (CRD42 016043311), is available at <http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016043311>. To focus the search upon high-quality systematic reviews, we searched two databases of systematic reviews: Cochrane Database of Systematic Reviews (Wiley) issue 7 of 12 2016, Database of Abstracts of Reviews of Effects (Wiley) issue 2 of 4 2015 (latest available). In addition, we searched Ovid MEDLINE^®^ In-Process & Other Non-Indexed Citations and Ovid MEDLINE^®^ 2015 with a systematic review filter available from CADTH.[@b12-copd-12-1705] All search results were screened for title and abstract by one reviewer (JN), and 20% of the results were screened by a second reviewer (KH-M) to ensure comparability. Two reviewers screened the search results at the full paper review stage. The search strategy (ran up to October 1, 2016) combined database-specific thesaurus headings and keywords describing COPD and self-management: exp Pulmonary Disease, Chronic Obstructiveemphysema\$.tw.(chronic\$ adj3 bronchiti\$).tw.(obstruct\$ adj3 (pulmonary or lung\$ or bronch\$ or respirat\$)).tw.(COPD or COAD or COBD or AECB).tw.or/1--5exp Self Care/(self-manag\$ or self manag\$ or self-car\$ or self car\$ or self-administ\$ or self administ\$).tw.(patient\$ adj3 (focus\$ or participat\$ or centr\$ or center\$ or empower\$ or support\$ or collaborat\$ or co-operat\$ or cooperat\$)).tw.or/7--96 and 10.

The review approach provides an overview of existing systematic reviews and is particularly helpful where multiple systematic reviews have been conducted. A review also provides an opportunity to compare the summaries and findings of previous reviews. In the present review, both a meta-analysis and narrative synthesis were conducted. The narrative synthesis compared the overview of findings as presented by the original authors, whereas meta-analyses were conducted on data from individual studies presented within the reviews. These quantitative analyses are helpful to determine the effectiveness of SM interventions and the factors that influence their effectiveness.

To be eligible for the narrative synthesis, reviews had to focus upon interventions that targeted self-management. We sought to explore variations in definitions of self-management used by previous authors, and thus reviews were eligible if they specified they focused on SMIs, irrespective of the definition they applied. Reviews that focused on SMIs in addition to other types of interventions (eg, pulmonary rehabilitation, supervised exercise programs) were only eligible if the SMIs could be clearly separated from the other interventions. Reviews of interventions delivered in primary, secondary, tertiary, outpatient, or community care were eligible.

To be eligible for the quantitative analyses, randomized controlled trials delivered in primary, secondary, tertiary, outpatient, or community care were eligible if they 1) targeted patients with COPD (diagnosed by either a clinician/health care practitioner and/or agreed spirometry criteria, ie, forced expiratory volume in 1 second (FEV~1~)/forced vital capacity (FVC) \<70%),[@b13-copd-12-1705] 2) compared the SMI to a comparison group that received usual care during the study period, and 3) had a measure of HRQOL as an outcome measure. Studies were excluded if they involved mixed disease populations where COPD patients could not be separated for analysis. [Figure 1](#f1-copd-12-1705){ref-type="fig"} provides a PRISMA diagram of reviews, and the trials within reviews, eligible for inclusion.

Primary outcome
---------------

The primary outcome measure was HRQOL measured by the Saint George Respiratory Questionnaire (SGRQ). The SGRQ is a disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease.[@b14-copd-12-1705] The measure provides a total score and subdomain scores of symptoms (frequency and severity of symptoms), activities (activities that cause or are limited by breathlessness), and impacts (social functioning and psychological disturbances resulting from airways disease) and is the most frequently used disease-specific measure of HRQOL in this population group.[@b15-copd-12-1705] Where trials did not use the SGRQ, scores from alternative HRQOL measures were used; the Chronic Respiratory Disease Questionnaire (CRQ), Clinical COPD Questionnaire (CCQ), or Sickness Impact Profile (SIP).[@b16-copd-12-1705]--[@b18-copd-12-1705] We combined scores across different questionnaires for meta-analyses, as total SGRQ, CRQ, CCQ, and SIP scores have been shown to correlate well and as subdomain constructs share conceptual similarity.[@b19-copd-12-1705]--[@b22-copd-12-1705] Studies using alternative HRQOL measures were not eligible.

Classification of intervention content and intervention delivery features
-------------------------------------------------------------------------

The Behavior Change Techniques Taxonomy version 1 (BCTTv1) was used to code the content of intervention descriptions.[@b9-copd-12-1705] Intervention descriptions were separately coded for self-management behaviors that targeted 1) symptoms, 2) physical activity, and 3) mental health. For instance, the description "patients were instructed to set themselves a walking goal each day" would be coded as "goal setting (behavior)" only for "physical activity" and not "mental health self-management" or "symptoms self-management." Consequently, it is important to use an outcome measure where changes in score reflect a change in these behaviors; and these three behaviors of symptoms, physical activity, and mental health directly map on to the three subdomains of the SGRQ (ie, Symptoms, Activities, and Impacts, respectively). Examples of symptom-specific behaviors may include teaching appropriate inhalation techniques or mucus-clearing techniques.[@b2-copd-12-1705] In contrast, physical activity behaviors may be structured exercise programs, techniques on how to incorporate light activity into daily routine, or energy conservation techniques.[@b2-copd-12-1705] Finally, mental health-focused behaviors may include trying to teach patients communication strategies to help communicate mental health concerns, distraction techniques, relaxation exercises, or stress counseling.[@b2-copd-12-1705]

To identify whether any features of the delivery of the intervention itself influenced effectiveness, interventions were coded for intervention provider (multidisciplinary team or single practitioner), intervention format (individual or group-based), and intervention length (single session or multiple session).[@b23-copd-12-1705] The BCTs identified and intervention features of delivery were coded independently by one reviewer (JN) and checked independently by another (KH-M) (κ=0.89; 95% CI =0.82, 0.96). To determine the length of an intervention, the end point was defined as the final time participants received intervention content from the intervention provider. Intervention contacts solely for data collection or for following up on participants without new content were not classed as intervention sessions. To assess whether intervention effects depend on disease severity, studies were divided into those with patients with mean predicted FEV~1~ score \<50% or ≥50% at baseline.[@b13-copd-12-1705]

Data relating to the number of COPD-related emergency department (ED) visits and/or hospital admissions were extracted from eligible studies, where reported, and used to see whether fewer ED visits were reported in patients receiving SMIs compared to patients receiving usual care. Subsequently, SMIs were divided between those with and without BCTs targeting mental health and physical activity in order to examine whether they had a difference in the size of their effect in comparison to patients who received usual care.

Data extraction and analysis
----------------------------

The original studies were sought for further data extraction, to supplement the information reported in the reviews. Data reported at the follow-up time point most closely following the end point of the intervention period were used for meta-analyses. We decided to group patients across time points as patients with COPD have high mortality rates; of those patients who are admitted, 15% will die within 3 months,[@b24-copd-12-1705] 25% will die within 1 year,[@b2-copd-12-1705] and 50% within 5 years.[@b25-copd-12-1705] While prespecifying a follow-up time point limits the bias of treatment reactivity, we may be excluding patients with shorter survival, who may not necessary survive to a later time point, who are likely to be those most in need of interventions that improve HRQOL. Sensitivity analyses were performed for studies collecting outcome data at less than 6 months and 6-month and 12-month follow-up to explore any potential heterogeneity in the overall analysis. Data from intention-to-treat analyses were used where reported. If two interventions were compared against a control group (eg, action plans vs education vs usual care), data from both intervention arms were included in the main comparison and the number of participants in the control group was halved for each comparison.[@b26-copd-12-1705]

Postintervention outcomes reported as mean and SD were used for analysis. Mean change scores were used if postintervention scores were unavailable. When mean and SD values were unavailable, missing data were imputed using the median instead of the mean and by estimating the SD from the standard error, confidence intervals (CIs), or interquartile range.[@b26-copd-12-1705],[@b27-copd-12-1705]

Standardized mean differences (SMDs) with 95% CIs were calculated and pooled using a random effects model for all studies. Dichotomous and continuous outcomes were merged using Comprehensive Meta-Analysis (CMA) software (v2.2, Biostat; Englewood, NJ, USA) to produce SMDs for each study, which are equivalent to Cohen's *d*. SMD values of at least 0.2, 0.5, and 0.8 are indicative of small, medium, and large effect sizes, respectively.[@b28-copd-12-1705] Heterogeneity across studies was assessed using Cochran *Q* test and *I*^2^ test statistics.[@b26-copd-12-1705]

Random effects subgroup analyses with *Q* statistic tests were conducted using CMA software. Univariate moderator analyses were conducted to compare effect size between SMIs with moderate/severe COPD, single/multiple sessions, and single/multiple practitioners. Univariate moderator analyses were also used to compare SMIs with/without BCTs targeting mental health self-management and physical activity to examine whether they differed in effect for the number of ED visits in comparison to patients receiving usual care. Random effects univariate meta-regression was conducted using CMA software to examine whether the number of BCTs coded across SMIs was predictive of effectiveness.

Results
=======

Narrative synthesis
-------------------

Eleven reviews were eligible for inclusion,[@b7-copd-12-1705],[@b10-copd-12-1705],[@b11-copd-12-1705],[@b29-copd-12-1705]--[@b36-copd-12-1705] covering 66 clinical trials ([Figure 1](#f1-copd-12-1705){ref-type="fig"}). The decision over whether to include three reviews warranted further discussion and the rationale for inclusion/exclusion is detailed in Supplementary material. Reviews varied widely in their definitions of self-management and the number of individual studies that met their inclusion criteria ([Tables 1](#t1-copd-12-1705){ref-type="table"} and [2](#t2-copd-12-1705){ref-type="table"}). Zwerink et al[@b7-copd-12-1705] reported a significant effect of SMIs on HRQOL but did state that "heterogeneity among interventions, study populations, follow-up time, and outcome measures makes it difficult to formulate clear recommendations regarding the most effective form and content of self-management in COPD". Jonkman et al[@b10-copd-12-1705] showed SMIs to improve HRQOL in COPD patients at 6 and 12 months but did not identify any components of the SMIs that were associated with the intervention. The more recent reviews had strict inclusion criteria and were smaller in size as a result.[@b30-copd-12-1705],[@b33-copd-12-1705],[@b34-copd-12-1705],[@b36-copd-12-1705] Harrison et al[@b33-copd-12-1705] and Majothi et al[@b34-copd-12-1705] focused on hospitalized and recently discharged patients. Harrison et al[@b33-copd-12-1705] did not find any significant differences in total or domain scores for HRQOL. In contrast, Majothi et al et al[@b34-copd-12-1705] did find a significant effect on total SGRQ, but stressed that this finding should be treated with caution due to variable follow-up assessments. Walters et al[@b36-copd-12-1705] focused on more restrictive criteria for interventions that were action plans and found no significant effect on HRQOL. Bentsen et al[@b30-copd-12-1705] were less clear in their definition of an SMI, and this may explain the smaller number of studies. The authors reported that the majority of studies showed a benefit on HRQOL, but no meta-analysis was performed.

Quantitative synthesis
----------------------

Twenty-six eligible, unique trials provide data on 28 intervention groups ([Figure 1](#f1-copd-12-1705){ref-type="fig"} and [Table 3](#t3-copd-12-1705){ref-type="table"}). In total, trials reported on 3,518 participants (1,827 intervention, 1,691 control) for this analysis. Mean age of participants was 65.6 (SD =1.6; range =45--89) years. The majority of participants were male (72%). Characteristics of included trials are reported in their respective reviews ([Table 2](#t2-copd-12-1705){ref-type="table"}). [Table 3](#t3-copd-12-1705){ref-type="table"} details which specific BCTs were used in each SMI. [Table 4](#t4-copd-12-1705){ref-type="table"} displays which intervention features and target behaviors were used in each SMI. SMIs showed a significant but small positive effect in improving HRQOL scores over usual care (SMD =−0.16; 95% CI =−0.25, −0.07; *P*=0.001). Statistical heterogeneity was moderate but significant (*I*^2^=36.6%; *P*=0.03), suggesting the need for further moderator/subgroup analyses ([Table 5](#t5-copd-12-1705){ref-type="table"}). When studies using measures other than the SGRQ (n=6) were excluded, SMIs continued to show a significant effect on improving HRQOL, which was of comparable effect size (SMD =−0.16; 95% CI =−0.26, −0.05; *P*=0.003). SMIs with 12-month follow-up (n=15) were significantly more effective than usual care (SMD =−0.16; 95% CI =−0.29, −0.03; *P*=0.02), but significant heterogeneity existed between studies (*I*^2^=53.4%; *P*=0.008). In trials with 6-month follow-up (n=10), there was no significant difference in effect between SMIs and control group on HRQOL (SMD =−0.11; 95% CI =−0.27, 0.04; *P*=0.14) and even heterogeneity between studies was not significant (*I*^2^=26.2%; *P*=0.20). In trials with a follow-up less than 6-month postintervention (n=7), SMIs were significantly more effective than usual care (SMD =−0.29; 95% CI =−0.48, −0.11; *P*=0.002) and there was no significant heterogeneity (*I*^2^=2.4%; *P*=0.41).

Intervention delivery features
------------------------------

In comparison to patients receiving usual care, there were no significant differences in effect size in between-group comparisons of 1) single session vs multiple session SMIs, 2) SMIs delivered by a single practitioner vs multidisciplinary teams, 3) SMIs targeting patients with moderate vs severe symptoms, and 4) individual-based vs group-based SMIs ([Table 5](#t5-copd-12-1705){ref-type="table"}). However, within-group moderator analysis showed 1) SMIs to be significantly effective in COPD patients with severe symptoms, whereas no significant effect was observed in studies that recruited patients with moderate symptoms; 2) significant improvement with SMIs delivered by a single practitioner, while no effect with multidisciplinary interventions; 3) no effect with single-session SMIs, but significant improvement with SMIs with multiple sessions; and 4) significant improvement in HRQOL was observed in both individual and group-based SMIs ([Table 5](#t5-copd-12-1705){ref-type="table"}).

SMIs targeting mental health had a significantly greater effect size than SMIs not targeting mental health management (Q=4.37; k=28; *P*=0.04) ([Table 5](#t5-copd-12-1705){ref-type="table"}). Within-group analysis showed SMIs that did not target mental health had no significant effect on HRQOL. There was no difference in effect size between SMIs targeting and not targeting physical activity, with both groups of SMIs showing significant improvement in improving HRQOL in comparison to usual care.

Intervention content
--------------------

All interventions were coded for at least one BCT that targeted symptom management. Of these 24 interventions, five targeted solely symptom management (20.8%), three targeted management of mental health concerns (12.5%), eleven targeted physical activity (45.8%), and five targeted all three behaviors (20.8%). The number of interventions reporting BCTs that target each of the three behaviors is presented in [Tables 3](#t3-copd-12-1705){ref-type="table"} and [4](#t4-copd-12-1705){ref-type="table"}. Across interventions, a mean of eight BCTs per intervention was coded (SD =3; range =3--13), with a mean of five BCTs (SD =2; range =2--10) for symptom management, one BCT (SD =1; range =0--4) for mental health management, and two BCTs (SD =3; range =0--10) for physical activity. For symptom management, the three most common BCTs reported were "instruction on how to perform a behavior" (n=23/24 trials; 95.8%), "information about health consequences" (n=21/24; 87.5%), and "action planning" (n=16/24; 66.7%). For physical activity, the three most common BCTs reported were "instruction on how to perform a behavior" (n=11/16 trials; 68.8%), "goal setting (behavior)" (n=8/16; 50%), and "demonstration of the behavior" (n=8/16 trials; 50%). For management of mental health concerns, the three most common BCTs reported were strategies to "reduce negative emotions" (n=4/8 trials; 50%), "provide social support (unspecified)" (n=3/8 trials; 37.5%), and "monitoring of emotional consequences" (n=3/8 trials; 37.5%). Sixty-six (70.9%) of the 93 BCTs in the BCTTv1 were not coded in any intervention. There was no significant association between the number of BCTs used and intervention effectiveness for improving HRQOL (β=−0.01; 95% CI =−0.04, 0.01; k=28; Q=1.75; *P*=0.19).

Health care use
---------------

Overall, patients who received SMIs had significantly fewer ED visits compared to those who received usual care (SMD =−0.13; 95% CI =−0.23, −0.03; n=15; *P*=0.02). There was no significant heterogeneity in the sample (*I*^2^=19.4%; *P*=0.24). The significant effect of SMIs on the number of ED visits in patients who received SMIs remained when examining only studies with a 12-month follow-up (SMD =−0.17, 95% CI =−0.27, −0.07; n=12; *P*=0.001) with no significant heterogeneity (*I*^2^=10.4%; *P*=0.34). Of the three intervention groups that did not have a 12-month follow-up, only one used a 3-month follow-up and the two were from the same study where a 6-month follow-up was used. Thus, meta-analyses were not performed for either 3-month or 6-month follow-up time points.

Within-group analyses revealed patients receiving SMIs targeting mental health made significantly fewer ED visits compared to patients receiving usual care (SMD =−0.22; 95% CI =−0.32, −0.11; k=5; *P*\<0.001). No difference was observed in the number of ED visits between patients receiving SMIs not targeting mental health and patients receiving usual care (SMD =0.001; 95% CI =−0.14, 0.14; k=10 *P*=0.99). This led to a significant between-group difference in effect between SMIs targeting mental health compared to SMIs not targeting mental health (Q=5.95; *P*=0.02).

Patients receiving SMIs targeting physical activity made significantly fewer ED visits compared to those who received usual care (SMD =0.20; 95% CI =−0.31, −0.08; k=8; *P*=0.001). No difference was observed between patients receiving SMIs not targeting physical activity and usual care (SMD =−0.03; 95% CI =−0.18, 0.12; k=7; *P*=0.68). In comparison to usual care, there was no difference in effect between SMIs targeting and not targeting physical activity (Q=3.03; k=15; *P*=0.08).

Discussion
==========

The meta-analysis showed SMIs were significantly more effective than usual care in improving HRQOL and reducing the number of ED visits in patients with COPD. In addition, moderator analyses provided specific detail of relevance for clinicians regarding the design, content, and implementation of intervention in practice. SMIs that specifically target mental health concerns alongside symptom management were significantly more effective in improving HRQOL and reducing ED visits than SMIs that focus on symptom management alone. Within-group analyses showed that HRQOL was significantly improved in 1) studies with COPD patients with severe level of symptoms but not in patients with a moderate level of symptoms, 2) single-practitioner based SMIs but not in SMIs delivered by a multidisciplinary team, 3) SMIs with multiple sessions but not in SMIs delivered in a single session, 4) both individual- and group-based interventions, and 5) SMIs that target physical activity. Our analysis also highlighted how different BCTs were utilized for the three different self-management behaviors.

Targeting of specific behaviors in self-management approaches may explain heterogeneity in effectiveness. Our review found SMIs that tackle mental health concerns are more effective than those aimed directly at respiratory health. Management of mental health problems is acknowledged as an important part of COPD care as comorbid mental health problems are common in COPD, with an estimated prevalence of 10%--42% for depression and 10%--60% for anxiety.[@b63-copd-12-1705]--[@b66-copd-12-1705] However, fewer than 30% of treatment providers adhere to current guidance for management of anxiety and depression in COPD.[@b67-copd-12-1705],[@b68-copd-12-1705] The nature and direction of the relationship between mental health and respiratory symptoms in COPD are difficult to disentangle.[@b69-copd-12-1705] Breathlessness may be a symptom of anxiety or COPD, and in turn, deteriorating respiratory health may trigger anxiety;[@b64-copd-12-1705] and anxiety is associated with more frequent hospital admissions for exacerbations.[@b69-copd-12-1705] It follows that SMIs targeting mental health have the potential to improve HRQOL. Overall, few of the identified SMIs contained BCTs that targeted mental health self-management, although the six SMIs with the highest effect sizes utilized BCTs that targeted mental health concerns ([Table 4](#t4-copd-12-1705){ref-type="table"}). The most commonly reported BCT to aid management of mental health was input to "reduce negative emotions." Interventions using this technique may improve patients' self-efficacy for managing their symptoms, which could reduce the likelihood of attending ED's at the onset of an exacerbation.[@b70-copd-12-1705] Alternatively, addressing mental health management may have an indirect effect in preventing a deterioration in clinical status by an improvement in mood, leading to greater willingness to engage in other preventative behaviors (eg, increased physical activity, medication adherence, improved nutritional diet).[@b71-copd-12-1705]

In both moderator analysis and within-group analyses, SMIs targeting physical activity did not demonstrate a greater improvement in HRQOL compared with SMIs that did not target physical activity. It is surprising that the effect was not stronger, as patients engaging in increased physical activity are less likely to experience deterioration in physical condition and acute exacerbation.[@b66-copd-12-1705],[@b72-copd-12-1705] In contrast, physical deconditioning and inactivity may lead to faster deterioration in clinical status and increase the likelihood of hospital admission.[@b64-copd-12-1705],[@b66-copd-12-1705] Zwerink et al[@b7-copd-12-1705] also reported no improved benefit in SMIs that targeted physical activity. Furthermore, [Table 4](#t4-copd-12-1705){ref-type="table"} highlights the wide variability in BCTs that were used when targeting physical activity; with interventions ranging from individualized, structured, supervised sessions to education on physical activity. It is important when reporting SMIs that target physical activity that authors are clear about what is being asked of the patient. The American Thoracic Society and European Respiratory Society's joint summary identifies physical activity outcomes as a priority for future research.[@b6-copd-12-1705] The summary states that determining the optimal level of instruction is a priority in design of future physical activity interventions (eg, how many sessions, over what time period, and what specific exercises). However, it is important to consider that an individually tailored approach is needed for patients with COPD where there is wide variability in capability and resources.

The most commonly identified BCTs varied for the three separate behaviors. Those coded for symptom management and physical activity were similar in that they used BCTs centered on information provision (eg, "Instruction on how to perform the behavior," "Information about health consequences," "Demonstration of the behavior"), whereas those coded for management of mental health concerns encourage more awareness and reflective thought processes (eg, "reduce negative emotions," "monitoring of emotional consequences"). It is possible that SMIs that targeted mental health management routinely displayed larger effect sizes as a consequence of the type of BCTs rather than the behavior targeted. Further research should attempt to disentangle the extent to which it is specific BCTs, or the behavior targeted, that is responsible for the intervention effect.

One recommendation from the recent HTA review on SMIs was that "Novel approaches to influence behavior change ... should be explored".[@b8-copd-12-1705] Our approach identifies that vast majority of potential BCTs in the taxonomy were not identified across studies, suggesting opportunities for novel intervention content. For instance, it was apparent that while SMIs targeting mental health were more effective in improving HRQOL (eg, "reduce negative emotions"), the BCTs employed in these studies were not those recommended in current guidance as core strategies of self-management for COPD (eg, goal setting, problem solving, action planning).[@b2-copd-12-1705],[@b6-copd-12-1705] Similarly, while action planning is seen as a key component of effective self-management,[@b2-copd-12-1705],[@b6-copd-12-1705]--[@b8-copd-12-1705] some theoretical models specify that action planning is not always sufficient for behavior change and that problem solving is required to effectively maintain behavior change.[@b71-copd-12-1705] As COPD is characterized by frequent relapses in the form of acute exacerbations, it was surprising that the BCT "problem solving" was only coded in two studies ([Table 4](#t4-copd-12-1705){ref-type="table"}). Future SMIs need to incorporate how to deal with problem solving as coping with the repeated occurrences of breathlessness and exacerbations (and the associated anxiety of these symptoms arising) is an inevitable predictor of HRQOL.[@b72-copd-12-1705]

Intervention providers should look at how they can deliver the core strategies of self-management (eg, goal setting, problem solving) in ways that work across multiple behaviors rather than feeling certain BCTs are only applicable to single behaviors (eg, action planning can only be used for symptom management but not when explaining physical activity). For instance, "body changes" referred to breathing/relaxation techniques. This was often used for a specific behavior, but patients may have better outcomes if they understand how breathing/relaxation techniques can be used for managing breathlessness, reducing stress, and improving lung capacity when physically active. Explaining how the same behavior can be applied across situations may also be a more understandable message for patients with poor health literacy, rather than them believing that certain behavioral techniques can only be applied in certain contexts, especially when elevated anxiety may impair cognitive processing of the most suitable course of action. Furthermore, from an implementation perspective, SMIs employing multidisciplinary teams for individual-based interventions did not confer any significant increase in effect size. This is an important finding for clinical practice as single practitioner and group-based interventions are potentially of lower cost as multiple patients can be seen in a single setting.[@b73-copd-12-1705]

An interesting finding from the narrative synthesis is that the number of eligible studies in Jonkman et al's[@b10-copd-12-1705],[@b11-copd-12-1705] reviews and Zwerink et al[@b7-copd-12-1705] was approximately double the number found in the other reviews. The majority of additional studies in these reviews were recent publications. This may suggest that the use of SMIs has increased in less than a decade. However, further inspection of the definitions highlight where disparities between previous reviews may exist. Walters et al[@b36-copd-12-1705] only allowed single component (action plans) interventions and found no effect, whereas Zwerink et al[@b7-copd-12-1705] and Jonkman et al[@b10-copd-12-1705] both found a significant effect but stipulated that SMIs had to have at least two components (eg, action plans, symptom monitoring, physical activity component, etc.). This review highlights how the definition of SMI directly influences whether an effect is found on HRQOL.

A number of the reviews attempted to summarize components of their contributing SMIs, but these were often limited in description and were often a mixture of BCTs (eg, problem solving, action planning) and target behaviors (eg, mental health, physical activity). Zwerink et al[@b7-copd-12-1705] and Jonkman et al[@b10-copd-12-1705] were the only reviews to conduct subgroup analyses to quantify what content of SMIs are most effective. Zwerink et al[@b7-copd-12-1705] attempted to look at SMIs that did and did not utilize action plans, exercise programs, and behavioral components. However, the definitions for each of these three subgroup analyses were ambiguous: 1) action plans had to focus on symptom management, and thus excludes action planning techniques when the target behavior is physical or mental health, 2) focusing on only standardized exercise programs neglects the ways physical activity may be encouraged in everyday life (eg, energy conservation techniques), and 3) the authors themselves state that "behavioral components" was "difficult to determine because of lack of detailed information". Jonkman et al's[@b11-copd-12-1705] subgroup analyses were based on the absence/presence of clear BCTs: management of psychological aspects, goal setting skills, self-monitoring logs, and problem-solving skills. However the authors 1) combined a number of chronic conditions (COPD, chronic heart failure, and Type 2 diabetes) and 2) did not differentiate between the individual BCTs and the target behaviors. To build upon these authors' previous work, we have used a standardized taxonomy with definitions for a wider array of BCTs and been more specific about the behavior the BCT is targeting. This allows better comparison of intervention content across studies and a more robust basis for synthesis. Ultimately, the increasing popularity and awareness of SMIs, but an increasing variation in definition, indicates a need for more structured guidance on what constitutes self-management so that both practitioners and patients are aware of what the content of self-management entails.

Strengths and limitations
-------------------------

Comparing the findings across reviews highlights how the definition of self-management had a direct impact on the number of eligible studies and consequently the conclusions drawn. The difference in conclusions further highlights the need for more detailed content analysis. The current analysis extracted robust empirical data from across reviews and their contributing clinical trials to examine intervention content and structure to isolate what factors may be essential for improving patient outcomes. The use of a standardized taxonomy of definitions allowed comparisons of intervention content across studies and provided a robust basis for synthesis. Our approach also highlighted specific BCTs used in a range of contexts to enable more discernment between intervention features and outcome effectiveness. We used a concise search strategy in order to identify individual trial data and perform novel forms of exploratory analysis that examined the effectiveness of individual intervention components. For this exploratory analysis, small and hard to find trials are unlikely to introduce components that do not occur in a range of other trials, and as such it is unnecessary to carry out an exhaustive search to identify all existing trials. However, it is important to stress that while we present a comprehensive summary of SMIs that have been reported in previous reviews, this review does not aim to present the most up-to-date evidence base as a number of more recent SMI trials will not have been captured in these reviews.

There are limitations to the study worth noting. The limited number of studies meant that single rather than multiple variables were entered into the moderator analyses. For example, we could compare single vs multiple session SMIs or individual vs group SMIs but could not examine combinations of the different variables in a multivariate analysis. Thus, while these univariate analyses can helpfully guide intervention development by highlighting potential associations, they should not be interpreted in an additive fashion. Furthermore, meta-regression findings do not imply causality, as factors entered into these analyses were not randomized groups in the analyses.

It was difficult to ascertain the intensity with which some BCTs were administered and the same BCT could be used with varying intensity, eg, the instructors could provide "Feedback on the behavior" on a daily or monthly basis. Ultimately, the utility of this secondary analysis is dependent on the reporting of intervention content by authors. It is possible that some BCTs were present in interventions, but not described in sufficient detail to allow coding. While we coded intervention manuals where available, there is a need for more transparency in intervention content in future studies.

Conclusion
==========

SMIs can improve HRQOL and reduce the number of ED visits for patients with COPD, but there is wide variability in effect. To be effective, future interventions should focus on tackling mental health concerns but need not entail multidisciplinary and individual-focused SMIs.

Supplementary material
======================

Three reviews were discussed for eligibility. A review by Walters et al[@b74-copd-12-1705] focused upon studies where the intervention could be defined as "\[...\] use of guidelines detailing self-initiated interventions (eg, changing medication regime \[...\]) which were undertaken in response to alterations in the state of the patients' COPD (eg, increase in breathlessness) \[...\]. An educational component was permitted if the duration was short, up to 1 hour.[@b74-copd-12-1705]"Action plans were explicitly described as a central component in the definitions of self-management used by a number of the review authors,[@b75-copd-12-1705]--[@b79-copd-12-1705] and as Walters et al's[@b74-copd-12-1705] definition was comparable to many of the definitions of self-management interventions used by other authors, we considered this review eligible.

In contrast, the focus of Jolly et al's review[@b80-copd-12-1705] was "self-management" interventions, but the number of interventions included far exceeded the number of studies commonly found in the other eligible reviews and many would not typically be considered self-management (eg, structured pulmonary rehabilitation programs). As it was not possible to identify those that were primarily self-management based, we excluded this review as it summarizes evidence of a wider array of interventions for chronic obstructive pulmonary disease than self-management interventions.

Jonkman et al[@b81-copd-12-1705] highlighted relevant studies in the search, but the focus of the analysis was on an individual patient data analysis and as such the overall findings are not relevant to the current narrative.

This study was supported by National Institute of Health Research (NIHR) Capability Funding from Newcastle Gateshead Clinical Commissioning Group (CCG).
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###### 

Definitions of "self-management" used across reviews

  Review                                      Self-management definition
  ------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Jonkman et al[@b11-copd-12-1705]            Interventions providing information ... and including minimally two of the following components: 1) stimulation of sign/symptom monitoring; 2) education in problem-solving skills, ie, self-treatment of acute exacerbations and stress/symptom management; 3) smoking cessation ... 4) medical treatment adherence; 5) physical activity; or 6) improving dietary intake.
  Jonkman et al[@b10-copd-12-1705]            In addition to education about the condition ... two of the following components ... : 1) stimulation of sign/symptom monitoring, 2) education in problem-solving skills (ie, managing acute exacerbations/symptoms, resource utilisation), ... 3) medication adherence, 4) physical activity, 5) dietary intake, and/or 6) smoking cessation.
  Zwerink et al[@b7-copd-12-1705]             Interventions required an iterative interaction process between participant and health care provider, preferably goal formulation and feedback and two of the following: smoking cessation, self-recognition/self-treatment of exacerbations, exercise/physical activity component, dietary advice, medication advice, or coping with breathlessness. Participant education only intervention were excluded.
  Adams et al[@b29-copd-12-1705]              Education (giving information alone) and/or behavioral support (providing tools to modify behaviors) and/or motivational (linking specific goals for behavioral changes to clinical information)
  Bourbeau[@b32-copd-12-1705]                 Education program included training that integrated specific skills for patients to control their disease and live functional lives. Program could also include education about acute exacerbation recognition and action to be taken, as well as periodic home visits/telephone calls provided by a health professional
  Blackstock and Webster[@b31-copd-12-1705]   Education focusing on changing health behaviors through knowledge, goal setting, and development of action plans. Needed at least one occasion where the participant(s) had face-to-face interaction with the health professional. Education not delivered in a formal manner was considered usual care
  Harrison et al[@b33-copd-12-1705]           Action plan involving symptom monitoring and medical management as well as education providing knowledge and information on decision-making. Must include two of following: self-efficacy, problem solving, resource utilization, collaboration, emotional management, role management, and goal setting. Excluded action plans alone and supervised exercise training.
  Monninkhof et al[@b35-copd-12-1705]         Could involve COPD education and/or self-treatment (action plan) guidelines. Education included written material or structured verbal interaction with a health care provider, but as part of a programme to improve COPD knowledge and understanding. Self-treatment guidelines (action plan) were written plans for self-management of exacerbations.
  Walters et al[@b36-copd-12-1705]            Use of guidelines detailing self-initiated interventions (ie, changing medication regime, visiting GP/hospital), which were undertaken in response to alterations in the patients' COPD (eg, increase in breathlessness, sputum). Educational component permitted if duration was up to 1 hour. Excluded broader self-management support interventions.
  Majothi et al[@b34-copd-12-1705]            Included one or more components commonly included in self-management interventions, such as action plans, exercise, education, inhaler technique, bronchial hygiene and breathing techniques, stress management and relaxation, nutritional programs, patient empowerment, support groups, and telecare
  Bentsen et al[@b30-copd-12-1705]            Self-management is defined as the individual's ability to manage his/her symptoms, treatment, physical and psychosocial consequences, and lifestyle changes when living with a chronic condition

###### 

Overlap of individual studies across reviews

  Individual studies                              Reviews   Total                                        
  ----------------------------------------------- --------- ------- ---- --- --- --- --- --- --- --- --- ---
  Bourbeau et al 2003[@b37-copd-12-1705]          X         X       X    X   X   X                   X   7
  Watson et al 1997[@b38-copd-12-1705]            X         X            X   X   X       X   X           7
  Gallefoss et al 1999[@b39-copd-12-1705]         X                 X    X   X   X       X               6
  Emery et al 1998[@b40-copd-12-1705]                               X    X   X   X       X               5
  Garcia-Aymerich et al 2007[@b41-copd-12-1705]   X         X       X                X           X       5
  Monnonkhof et al 2004[@b42-copd-12-1705]        X         X       X    X                           X   5
  Bucknall 2012[@b43-copd-12-1705]                X         X                        X           X       4
  Littlejohns 1991[@b44-copd-12-1705]                                    X   X   X       X               4
  Wood-Baker et al 2006[@b45-copd-12-1705]        X         X                        X       X           4
  Coultas et al 2005[@b46-copd-12-1705]           X         X       X                                    3
  Hermiz et al 2002[@b47-copd-12-1705]                                   X           X           X       3
  Khdour et al 2009[@b48-copd-12-1705]            X         X       X                                    3
  McGeoch et al 2006[@b49-copd-12-1705]           X         X                                X           3
  Ninot et al 2011[@b50-copd-12-1705]             X                 X                                X   3
  Rice et al 2010[@b51-copd-12-1705]              X         X       X                                    3
  Wakabayashi et al 2011[@b52-copd-12-1705]       X         X       X                                    3
  Bischoff et al 2012[@b53-copd-12-1705]          X         X                                            2
  Fan et al[@b54-copd-12-1705]                    X         X                                            2
  Koff et al 2009[@b55-copd-12-1705]                        X       X                                    2
  Taylor et al 2012[@b56-copd-12-1705]            X         X                                            2
  Trappenburg et al 2011[@b57-copd-12-1705]       X         X                                            2
  Zwar et al 2012[@b58-copd-12-1705]              X         X                                            2
  Faulkner 2010[@b59-copd-12-1705]                                  X                                    1
  Kheirabadi 2008[@b60-copd-12-1705]                                X                                    1
  Moullec 2008[@b61-copd-12-1705]                                   X                                    1
  Rootmensen 2008[@b62-copd-12-1705]                                                         X           1
  Total                                           18        17      14   7   5   5   4   4   4   3   3   

###### 

BCTs used across studies eligible in meta-analysis

  --
  --

**Abbreviations:** BCT, behavior change technique; SMD, standardized mean differences; MM, nurse-assisted medical management; CM, nurse-assisted collaborative management.

###### 

Intervention features and number of BCTs targeting different behaviors across SMIs

  Intervention studies grouped by effect size         SMD     *P*-value     Number of BCTs targeted for each behavior   Intervention features (1 = Yes)                       
  --------------------------------------------------- ------- ------------- ------------------------------------------- --------------------------------- ---- ---- ---- ---- ----
  Medium effect size (SMD ≥0.5)                                                                                                                                               
   Moullec 2008[@b61-copd-12-1705]                    −2.44   \<**0.001**   8                                           2                                 2    4    1    1    --
   Emery et al 1998[@b40-copd-12-1705]; exercise      −0.74   **0.03**      9                                           2                                 4    3    1    1    --
   Koff et al 2009[@b55-copd-12-1705]                 −0.71   **0.03**      8                                           7                                 1    --   --   1    1
  Small effect size (0.5\> SMD ≥0.2)                                                                                                                                          
   Kheirabadi 2008[@b60-copd-12-1705]                 −0.42   0.17          9                                           6                                 2    1    1    1    NR
   Bucknall et al 2012[@b43-copd-12-1705]             −0.36   **0.05**      15                                          12                                3    --   --   1    1
   Bourbeau et al 2003[@b37-copd-12-1705]             −0.35   **0.02**      15                                          7                                 2    6    --   1    1
   Wakabayashi et al 2011[@b52-copd-12-1705]          −0.26   0.21          4                                           3                                 --   1    --   1    --
   Ninot et al 2011[@b50-copd-12-1705]                −0.24   0.46          9                                           4                                 --   5    1    1    1
   Rice et al 2010[@b51-copd-12-1705]                 −0.23   **0.02**      13                                          8                                 4    1    NR   1    1
   Khdour et al 2009[@b48-copd-12-1705]               −0.20   0.21          11                                          9                                 --   2    --   1    1
  Limited effect (SMD \<0.2)                                                                                                                                                  
   Coultas 2005[@b46-copd-12-1705]; MM                −0.19   0.43          3                                           3                                 --   --   --   1    1
   Coultas 2005[@b46-copd-12-1705] CM                 −0.18   0.45          3                                           3                                 --   --   --   1    1
   Gallefoss et al 1999[@b39-copd-12-1705]            −0.17   0.55          8                                           8                                 --   --   1    1    --
   Garcia-Aymerich et al 2007[@b41-copd-12-1705]      −0.16   0.55          6                                           5                                 --   1    --   1    --
   Trappenburg et al 2011[@b57-copd-12-1705]          −0.14   0.35          8                                           7                                 --   1    --   1    1
   Littlejohns et al 1991[@b44-copd-12-1705]          −0.13   0.45          4                                           4                                 --   --   --   1    1
   Rootmensen 2008[@b62-copd-12-1705]                 −0.12   0.45          6                                           6                                 --   --   --   --   1
   Hermiz et al 2002[@b47-copd-12-1705]               −0.10   0.54          5                                           4                                 --   1    --   --   1
   McGeoch et al 2006[@b49-copd-12-1705]              −0.09   0.58          7                                           5                                 --   2    --   --   1
   Fan et al 2012[@b54-copd-12-1705]                  −0.04   0.79          6                                           4                                 1    1    1    1    1
   Bischoff et al 2012[@b53-copd-12-1705]             −0.03   0.88          8                                           6                                 1    1    --   1    1
   Faulkner 2010[@b59-copd-12-1705]                   −0.02   0.96          10                                          2                                 --   8    1    1    1
   Monninkhof et al 2004[@b42-copd-12-1705]           −0.02   0.90          12                                          5                                 --   7    1    1    --
   Taylor et al 2012[@b56-copd-12-1705]               −0.02   0.94          18                                          10                                6    2    1    1    1
   Watson et al 1997[@b38-copd-12-1705]               0.00    1.00          8                                           6                                 --   2    --   --   --
   Emery et al 1998[@b40-copd-12-1705]; no exercise   0.04    0.91          6                                           2                                 4    --   1    1    --
   Zwar et al 2012[@b58-copd-12-1705]                 0.06    0.54          5                                           4                                 --   1    --   1    --
   Wood-Baker et al 2006[@b45-copd-12-1705]           0.21    0.25          3                                           3                                 --   --   --   --   --

**Notes:**

Intervention delivered by a single provider (of any profession) rather than multidisciplinary team. Bold values are statistically significant.

**Abbreviations:** BCT, behavior change technique; SMD, standardized mean difference; SMI, self-management intervention; MM, nurse-assisted medical management; CM, nurse-assisted collaborative management; NR, not reported.

###### 

SMD, 95% CIs for the effect of self-management interventions compared with control conditions on measures of health-related quality of life, with measures of heterogeneity

  Moderators                                                  Number of interventions   Number of participants within trials   Measure of effect                                    
  ----------------------------------------------------------- ------------------------- -------------------------------------- ------------------- ------- ------------------------ -------------
  Overall effect                                              28                        3,518                                  1,827               1,691   −0.16 (−0.25 to −0.07)   **0.001**
  Severity[a](#tfn5-copd-12-1705){ref-type="table-fn"}                                                                                                                              
   Moderate                                                   10                        1,172                                  610                 562     −0.12 (−0.28 to 0.03)    0.12
   Severe                                                     14                        1,644                                  874                 770     −0.21 (−0.35 to −0.08)   0.01
   Between group                                                                                                                                                                    0.39
  Model of care[b](#tfn6-copd-12-1705){ref-type="table-fn"}                                                                                                                         
   Single practitioner                                        17                        2,297                                  1,204               1,093   −0.17 (−0.29 to −0.06)   \<**0.01**
   Multidisciplinary team                                     9                         1,117                                  581                 536     −0.10 (−0.27 to 0.07)    0.23
   Between group                                                                                                                                                                    0.49
  Duration of intervention                                                                                                                                                          
   Single session                                             5                         637                                    321                 316     −0.03 (−0.23 to 0.17)    0.77
   Multiple session                                           23                        2,881                                  1,506               1,375   −0.19 (−0.29 to −0.09)   \<**0.001**
   Between group                                                                                                                                                                    0.17
  Session format                                                                                                                                                                    
   Individual                                                 17                        2,301                                  1,182               1,119   −0.14 (−0.25 to −0.02)   **0.02**
   Group                                                      10                        789                                    420                 369     −0.20 (−0.39 to 0.01)    **0.04**
   Between group                                                                                                                                                                    0.56
  Mental health                                                                                                                                                                     
   Targeted                                                   11                        1,313                                  698                 615     −0.27 (−0.41 to −0.13)   \<**0.001**
   Not targeted                                               17                        2,205                                  1,129               1,076   −0.08 (−0.19 to 0.02)    0.12
   Between group                                                                                                                                                                    **0.04**
  Physical activity                                                                                                                                                                 
   Targeted                                                   18                        2,550                                  1,297               1,253   −0.17 (−0.28 to −0.05)   \<**0.01**
   Not targeted                                               10                        968                                    530                 438     −0.14 (−0.30 to −0.02)   0.08
   Between group                                                                                                                                                                    0.83

**Notes:** The number of participants has now been added as additional columns. The number of trials will not always equal 28 as missing data in some studies.

Sample were, at baseline, predominantly classified as severe according to GOLD criteria. Studies may not have actively recruited a severe sample.

Intervention was delivered by a single provider (of any profession) rather than multidisciplinary team. Bold values indicate significant values.

**Abbreviations:** CI, confidence interval; GOLD, Global Initiative for Chronic Obstructive Lung Disease; SMD, standardized mean difference.
